Literature DB >> 17079807

The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer.

Isis W Gayed1, H Helen Liu, Syed Wamique Yusuf, Ritusko Komaki, Xiong Wei, Xuanmin Wang, Joe Y Chang, Joseph Swafford, Lyle Broemeling, Zhongxing Liao.   

Abstract

UNLABELLED: The detection of myocardial perfusion abnormalities after radiation therapy (RT) has been investigated previously in patients with lymphoma and breast cancer. However, the prevalence and association of such abnormalities with RT in esophageal cancer patients have not been investigated previously.
METHODS: The prevalence of myocardial perfusion abnormalities detected using gated myocardial perfusion imaging (GMPI) in patients with esophageal cancer after RT (RT group) was compared with that in patients with esophageal cancer who did not undergo RT (NRT group). The patients' data were extracted from a prospectively collected database. The results of GMPI that were read by multiple readers were tested further by an expert reader who was unaware of the patients' clinical information. This reader's findings were correlated with the different RT isodose lines as seen in the CT for RT planning. Isodose lines containing the affected segments in GMPI as well as the rest of the left ventricle were recorded. Additionally, information with regard to the mean radiation dose to the heart for each patient was collected. An overall, mean radiation dose to the heart in patients with abnormal GMPI studies was compared with that in patients with normal GMPI studies.
RESULTS: Fifty-one patients were included, 26 in the RT group and 25 in the NRT group. The mean and median interval between RT and GMPI was 7.5 and 3.0 mo, respectively. We identified myocardial perfusion defects in 14 patients (54%) in the RT group and in 4 patients (16%) in the NRT group. Eleven patients (42%) in the RT group had mild inferior wall ischemia versus only 1 patient (4%) in the NRT group (P = 0.001). All of the patients with inferior wall ischemia had distal esophageal cancer. The remaining 12 patients in the RT group and 21 patients in the NRT group had normal GMPI results. The mean left ventricular ejection fraction was 59.0% +/- 10.7% in the RT group and 59.3% +/- 9.8% in the NRT group (P = not significant). Good agreement was found between the GMPI results interpreted by multiple readers and those of the single expert reader (kappa = 0.84). In 7 of 10 patients (70%) who had abnormal GMPI results in the RT group, the myocardial perfusion defect was encompassed in RT isodose lines >/= 45 Gy, whereas in only 5 of 20 patients (25%) the normal left ventricle was included in the RT isodose line >/= 45 Gy.
CONCLUSION: RT is associated with a high prevalence of inferior left ventricular ischemia, as detected using GMPI in patients with distal esophageal cancer. Most perfusion defects are encompassed within an isodose line >/= 45 Gy in the RT plan.

Entities:  

Mesh:

Year:  2006        PMID: 17079807

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  35 in total

1.  Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.

Authors:  Andre Konski; Tianyu Li; Michael Christensen; Jonathan D Cheng; Jian Q Yu; Kevin Crawford; Oleh Haluszka; Jeffrey Tokar; Walter Scott; Neal J Meropol; Steven J Cohen; Alan Maurer; Gary M Freedman
Journal:  Radiother Oncol       Date:  2012-06-07       Impact factor: 6.280

Review 2.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

3.  Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.

Authors:  Steven H Lin; Ning Zhang; Joy Godby; Jingya Wang; Gary D Marsh; Zhongxing Liao; Ritsuko Komaki; Linus Ho; Wayne L Hofstetter; Stephen G Swisher; Reza J Mehran; Thomas A Buchholz; Linda S Elting; Sharon H Giordano
Journal:  Cancer       Date:  2015-12-30       Impact factor: 6.860

4.  Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy.

Authors:  Guillaume S Chevrollier; Danica N Giugliano; Francesco Palazzo; Scott W Keith; Ernest L Rosato; Nathaniel R Evans Iii; Adam C Berger
Journal:  J Gastrointest Surg       Date:  2019-02-26       Impact factor: 3.452

5.  PET/CT demonstrates increased myocardial FDG uptake following irradiation therapy.

Authors:  K Zöphel; C Hölzel; M Dawel; T Hölscher; C Evers; J Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-02       Impact factor: 9.236

6.  Different Sequences of Fractionated Low-Dose Proton and Single Iron-Radiation-Induced Divergent Biological Responses in the Heart.

Authors:  Sharath P Sasi; Xinhua Yan; Marian Zuriaga-Herrero; Hannah Gee; Juyong Lee; Raman Mehrzad; Jin Song; Jillian Onufrak; James Morgan; Heiko Enderling; Kenneth Walsh; Raj Kishore; David A Goukassian
Journal:  Radiat Res       Date:  2017-06-14       Impact factor: 2.841

7.  Radiation-induced myocardial damage indicated by focal defect on 123I-MIBG SPECT.

Authors:  Takashi Norikane; Yuka Yamamoto; Yasukage Takami; Katsuya Mitamura; Hanae Arai-Okuda; Ryosuke Tani; Yoshihiro Nishiyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-15       Impact factor: 9.236

Review 8.  Radiation-Induced Cardiovascular Disease.

Authors:  Deepa Raghunathan; Misha Iftikhar Khilji; Saamir A Hassan; Syed Wamique Yusuf
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

9.  The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy.

Authors:  Isis Gayed; Salman Gohar; Zhongxing Liao; Mary McAleer; Roland Bassett; Syed Wamique Yusuf
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-22       Impact factor: 2.357

Review 10.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.